A Randomized, Double‐Blind, Placebo‐Controlled Study of Breath Powered Nasal Delivery of Sumatriptan Powder (AVP‐825) in the Treatment of Acute Migraine (The TARGET Study)

By  

HEADACHE, Vol. 55, Iss. 1, 2015-01 ,pp. : 88-100

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg

By Diener Hans-Christoph  

Current Medical Research and Opinion, Vol. 21, Iss. 10, 2005-10 ,pp. : 1603-1610

Informa Healthcare

Access to resources Recommend Favorite

Greater occipital nerve blockade for the treatment of chronic migraine: a randomized, multicenter, double‐blind, and placebo‐controlled study

By  

ACTA NEUROLOGICA SCANDINAVICA (ELECTRONIC), Vol. 132, Iss. 4, 2015-10 ,pp. : 270-277

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Double‐Blind, Placebo‐Controlled Study of Repetitive Transnasal Sphenopalatine Ganglion Blockade With Tx360® as Acute Treatment for Chronic Migraine

By  

HEADACHE, Vol. 55, Iss. 1, 2015-01 ,pp. : 101-116

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomized placebo-controlled cross-over designs in clinical trials: a gold standard to be reassessed

By Leonard Guillaume   Lafrenaye Sylvie   Goffaux Philippe  

Current Medical Research and Opinion, Vol. 28, Iss. 2, 2012-02 ,pp. : 245-248

Informa Healthcare

Access to resources Recommend Favorite